Festoon formation after infraorbital botulinum A toxin: A case report

Dermatologic Surgery

Volumn 29, Issue 5, 2003, Pages 560-561

  Goldman, Mitchel P ^a   Carruthers, Jean ^b   Carruthers, Alastair ^b  

^a La Jolla Spa MD   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; EPICANTHUS; ESTHETIC SURGERY; EYELID; EYELID RECONSTRUCTION; FACE MALFORMATION; HUMAN; MALE; MUSCLE WEAKNESS; ORBICULARIS OCULI MUSCLE; PRIORITY JOURNAL; TREATMENT PLANNING;

BLEPHAROPLASTY; BOTULINUM TOXIN TYPE A; EYELID DISEASES; EYELIDS; FACIAL PARALYSIS; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS;

EID: 0037610876     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29130.x     Document Type: Article

References (6)

1. Flynn TC, Carruthers JA, Carruthers JA. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widen the eye. Dermatol Surg 2001;27:703-8.
2. Keen M, Blitzer A, Binder W, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebocontrolled study. Plast Reconstr Surg 1994;94:94-9.
3. Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 1996;34(5 Pt 1):788-97.
4. Klein AW. Cosmetic therapy with botulinum toxin. Dermatol Surg 1996;22:756-9.
5. Carruthers A, Carruthers JDA. The use of botulinum toxin to treat glabellar frown lines and other facial wrinkles. Cosmet Dermatol 1997;7:11-5.
6. Klein AW. Complications and adverse reactions with the use of Botulinum toxin. Semin Cutan Med Surg 2001;20:109-20.